Correspondence on 'Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors' by Musacchio et al.

Fatma Ferda Verit,Fuat Demirkiran

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society（2023）

引用 0|浏览0

暂无评分

摘要

We would like to thank Dr Musacchio et al for their fine article.[1][1] In this retrospective study, it was suggested that patients with BRCA variants of unknown significance have survival outcomes similar to those of patients with BRCA wild type, and shorter progression-free survival than mutated

查看译文

关键词

ovarian cancer,parp inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要